Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,032 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of CKD on Household Income.
Morton RL, Schlackow I, Gray A, Emberson J, Herrington W, Staplin N, Reith C, Howard K, Landray MJ, Cass A, Baigent C, Mihaylova B; SHARP Collaborative Group. Morton RL, et al. Among authors: gray a. Kidney Int Rep. 2017 Dec 23;3(3):610-618. doi: 10.1016/j.ekir.2017.12.008. eCollection 2018 May. Kidney Int Rep. 2017. PMID: 29854968 Free PMC article.
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
Morton RL, Schlackow I, Staplin N, Gray A, Cass A, Haynes R, Emberson J, Herrington W, Landray MJ, Baigent C, Mihaylova B; SHARP Collaborative Group. Morton RL, et al. Among authors: gray a. Am J Kidney Dis. 2016 Jan;67(1):31-9. doi: 10.1053/j.ajkd.2015.07.021. Epub 2015 Sep 16. Am J Kidney Dis. 2016. PMID: 26385817 Free PMC article. Clinical Trial.
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
Mihaylova B, Schlackow I, Herrington W, Lozano-Kühne J, Kent S, Emberson J, Reith C, Haynes R, Cass A, Craig J, Gray A, Collins R, Landray MJ, Baigent C; SHARP Collaborative Group. Mihaylova B, et al. Among authors: gray a. Am J Kidney Dis. 2016 Apr;67(4):576-84. doi: 10.1053/j.ajkd.2015.09.020. Epub 2015 Nov 18. Am J Kidney Dis. 2016. PMID: 26597925 Free PMC article. Clinical Trial.
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray MJ, Gray A, Baigent C, Mihaylova B; SHARP Collaborative Group. Schlackow I, et al. Among authors: gray a. Kidney Int. 2019 Jul;96(1):170-179. doi: 10.1016/j.kint.2019.01.028. Epub 2019 Mar 12. Kidney Int. 2019. PMID: 31005271 Free PMC article. Clinical Trial.
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Wanner C, Fellström B, Gray A, Landray MJ, Baigent C, Mihaylova B; SHARP Collaborative Group. Schlackow I, et al. Among authors: gray a. Heart. 2017 Dec;103(23):1880-1890. doi: 10.1136/heartjnl-2016-310970. Epub 2017 Aug 5. Heart. 2017. PMID: 28780579 Free PMC article.
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S, Schlackow I, Lozano-Kühne J, Reith C, Emberson J, Haynes R, Gray A, Cass A, Baigent C, Landray MJ, Herrington W, Mihaylova B; SHARP Collaborative Group. Kent S, et al. Among authors: gray a. BMC Nephrol. 2015 Apr 29;16:65. doi: 10.1186/s12882-015-0054-0. BMC Nephrol. 2015. PMID: 25924679 Free PMC article.
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs.
Kent S, Haynes R, Hopewell JC, Parish S, Gray A, Landray MJ, Collins R, Armitage J, Mihaylova B; HPS2-THRIVE Collaborative Group. Kent S, et al. Among authors: gray a. Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):348-54. doi: 10.1161/CIRCOUTCOMES.115.002592. Epub 2016 Jul 12. Circ Cardiovasc Qual Outcomes. 2016. PMID: 27407053 Clinical Trial.
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
HPS3/TIMI55-REVEAL Collaborative Group; Writing Committee; Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C, Murphy K, Wincott E, Baxter A, Goodenough R, Lay M, Hill M, Macdonnell S, Fabbri G, Lucci D, Fajardo-Moser M, Brenner S, Hao D, Zhang H, Liu J, Wuhan B, Mosegaard S, Herrington W, Wanner C, Angermann C, Ertl G, Maggioni A, Barter P, Mihaylova B, Mitchel Y, Blaustein R, Goto S, Tobert J, DeLucca P, Chen Y, Chen Z, Gray A, Haynes R, Armitage J, Baigent C, Wiviott S, Cannon C, Braunwald E, Collins R, Bowman L, Landray M; REVEAL Collaborative Group. HPS3/TIMI55-REVEAL Collaborative Group, et al. Among authors: gray a. Eur Heart J. 2022 Apr 6;43(14):1416-1424. doi: 10.1093/eurheartj/ehab863. Eur Heart J. 2022. PMID: 34910136 Free PMC article. Clinical Trial.
3,032 results